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Cardiometabolic risk factors, metabolic
syndrome and pre‑diabetes in adolescents
in the Sierra region of Ecuador
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Edgar W. Rojas6,8, Masato Nakazawa5 and Jay H. Shubrook4,9

Abstract
Background: Excess weight (overweight and obesity) is the major modifiable risk factor for type 2 diabetes mellitus
(T2DM) and other non-communicable diseases. However, excess weight may not be as predictive of diabetes risk as
once thought. While excess weight and other obesity-related non-communicable diseases are of growing concern
in low-middle income countries in Latin America, there is limited research on risk factors associated with T2DM in adolescents. This study investigated prevalence of overweight, obesity, prediabetes, diabetes and metabolic syndrome in
adolescents in Ecuador.
Methods: A cross-sectional study was conducted with 433 adolescents from two schools in a small urban center
in southern Ecuador and two schools in a large urban center in Quito. Risk factors were measured, including: height,
weight, BMI, waist-to-hip ratio, fasting glucose, lipid panel, and HbA1c. Multivariate analysis of variance (MANOVA)
was separately applied to risk factors and demographic factors as a set of dependent variables with sex, location and
their interaction included as predictors. An independent t test was run on the data at 95% confidence intervals for the
mean difference. The values for the triglycerides, LDL and VLDL were positively skewed. A Mann–Whitney U test was
run on these data.
Results: Using IOTF standards, 9.8% were overweight and 1.9% were obese. Only 1.6% of the sample met the criteria
for prediabetes by fasting glucose but 12.4% of the sample met the criteria for prediabetes by HbA1c. None of the
participants met criteria for diabetes. There were 2.3% of the participants that met the IDF criteria for metabolic
syndrome. Adolescents from the larger urban center had higher rates of prediabetes, higher mean HbA1c, blood pressure, lipid values, and lower HDL levels.
Conclusions: Use of HbA1c identified more adolescents with prediabetes than FBG. The HbA1c measure is an
attractive screening tool for prediabetes in developing countries. Although rates of obesity in Ecuadorian adolescents
are low there is significant evidence to suggest that prediabetes is permeating the smaller urban centers. Traditional
screening tools may underestimate this risk.
Background
In Latin America (LA), non-communicable diseases
(NCDs), including diabetes and cancers, are now among
the leading causes of mortality [1]. For example, rates of
diabetes in LA are predicted to increase by more than
*Correspondence: casapull@ohio.edu
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59%, with 39.9 million predicted to have diabetes by 2030
[2–4]. Excess body weight (overweight and obesity) has
been considered the key modifiable risk factor for type 2
diabetes mellitus (T2DM) and represents a major public
health concern both in terms of individual quality of life
and cost to health care systems in LA [1, 5]. Relatively
recent data (2010) suggest that about half of the adults in
LA are overweight or obese, up from 33.9% a decade earlier [6]. Adolescents in LA are not immune to this trend.
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In fact, the World Health Organization (WHO) is calling
childhood obesity “one of the most serious public health
challenges of the twenty first century [1]”. Countries
undergoing rapid demographic and dietary shifts due to
an evolving economic climate, such as many countries
in Latin America, are among the most vulnerable [1, 6].
A study in adolescent girls in low middle income countries (LMICs) found that LA and the Caribbean had the
highest regional prevalence of overweight in both rural
and urban areas [7]. Further, it was recently found that
the worldwide prevalence of diabetes may be significantly
underreported. The International Diabetes Federation
previously estimated that 420 million people have diabetes worldwide but it is believed that it is closer to 520 million people [8].
Ecuador is experiencing rapid socioeconomic and
demographic transition [9]. Few studies have investigated
how these changes have affected the adolescent population in Ecuador in terms of body weight, comorbidities,
and cardiometabolic risk factors. Census data indicate
that the prevalence of overweight in adolescents (aged
12–19) is 18.8%, obese 7.1%, overweight and obese (combined) is 26% [10] and that prevalence rates of overweight
and obesity in adolescents vary by region [10]. The urban
Sierra (22.4%), rural Sierra (16.8%) and the rural coastal
(15.2%) regions have the highest prevalence of overweight in adolescents. The highest prevalence of adolescent obesity is found in the Galapagos Islands province
(13.8%). Rural areas in the costal and Sierra regions had
the lowest rates of adolescent obesity (4.2%). Quito, the
capital, has prevalence rates of overweight and obese
adolescents of 18.8 and 5.5%, respectively [10].
Yepez et al. [11] estimates that the prevalence of overweight and obesity were 13.7 and 7.5%, respectively, in
a group of Ecuadorian adolescents. Ochoa-Aviles et al.
[12] reports overweight and obesity rates to be 18.0 and
2.1%, respectively. Adolescents from rural areas were 2 to
4-times more likely to present with higher levels of cholesterol, triglycerides, and lower levels of HDL than those
from the urban areas. Collectively, these studies demonstrate the need for further investigation into the health of
Ecuadorian adolescents [12].
The current study was designed to expand on the previous research to identify and more fully understand the
presence of overweight and obesity rates, cardiometabolic risk factors, prevalence of type 2 diabetes, prediabetes and metabolic syndrome in Ecuadorian adolescents.
Cariamanga, a small urban center in the southern Loja
province, and Pomasqui, a larger urban area within the
Quito Metropolitan District are the two areas included
in the study. We hypothesized that adolescents from the
smaller urban center of Cariamanga would have lower
rates of obesity, metabolic syndrome and diabetes, and
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fewer cardiometabolic risk factors than adolescents living
in the larger urban center of Pomasqui.

Methods
Study area

A cross-sectional study was conducted from March to
July 2015 in two urban centers in the Sierra region of
Ecuador. A total of four schools were used in this study,
two from larger and two from smaller urban regions. Participants were recruited from two high schools located in
Pomasqui, a densely populated urban Parrish belonging
to the Quito Metropolitan District in the northern part
of the country. Pomasqui (population 28,910) is located
along a major highway that connects Quito, the country’s
capital (population 1.6 million), with the Coastal region.
Agricultural activities are limited due to dry climate.
Most of the population works within the Metropolitan
district in commerce, manufacturing and service jobs.
They are, for the most part, low to low-middle income.
Participants were also recruited from two high schools
in the smaller urban center of Cariamanga (population
13,311) located in Calvas County in the southern Sierra
Loja Province. Most economic activity among permanent
residents involves commerce and service jobs. Because
it is the only urban center in the mostly rural Calvas
County, part of the population is involved in agricultural
production and the schools attract a transient adolescent
population from nearby rural villages. The population is
largely of low to low-middle income status.
Sampling

Adolescents ages 13–18 (N = 433) were recruited from
two schools in Pomasqui, (n = 219) and two schools in
Cariamanga (n = 214). As this was a community- based
study and the participants were limited to older adolescents, the participants were not subjected to Tanner staging (See Fig. 1).
Ethics

The investigative team obtained approval from the local
school rectors, the Ministry of Education and the Undersecretary of Education to conduct this study. Adolescents
were excluded from the study if they had any physical,
physiological, or other health issues (including pregnancy) that would preclude them from participation. A
research physician was on site to evaluate any participant
if it was unclear whether or not they were appropriate for
the study. Parental consent was obtained from parents/
guardians, and assent was obtained from all adolescents
under the age of 18 years. Informed consent was obtained
from all 18-year-old adolescents. All protocols were
approved by the Institutional Review Boards of Ohio
University and Pontifical Catholic University of Ecuador.
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sphygmomanometer (Welch Allyn DS66, Skaneateles Falls, NY) with an appropriate cuff size. Subjects
were seated with their backs and feet supported for at
least 5 min before blood pressure was measured. Measurements were repeated two additional times, with a
1–2 min interval between each reading. SBP and DBP
measurements were compared to percentile standards
for age, sex, and height. Measurements above the 95th
percentile were considered hypertensive [15]. Following
each BP measurement, resting heart rate (HR) was measured for the last 15 s of 1 min by a trained investigator
using the radial pulse. For all measurements, the average
of three measurements was used in analyses. Metabolic
syndrome was determined using the International Diabetes Federation (IDF) criteria for children and adolescents,
grouping those less than age 16 and those age 16 and
greater [16].

Consented for
anthropometrics and blood
lipids
N=460

Dropped 16 due to
invalid birthdates
N=444

Dropped 16 due to
Nanegalito sample excluded
N=428

Dropped 53 FBG due to
equipment malfuncon
FBG n=375

Valid Anthropometrics
and Blood Lipids
n=428

Fig. 1 Recruitment of participants, including drop outs at each stage
and remaining number of participants

Anthropometric measurement

Standard procedures were used for assessing anthropometric measures, including light clothing and no shoes.
Height was measured to the nearest 0.1 cm using a portable stadiometer (Seca 213 Mobile Stadiometer, Snoqualmie, WA) and weight to the nearest 0.1 kg using a
calibrated digital scale (Seca 874 Digital Scale). Height
and weight were used to calculate BMI (kg/m2). BMI
percentile was used to determine weight status according to age and sex-specific growth charts published by
the World Health Organization (WHO) [13] and the
International Obesity Task Force (IOTF) [14]. Abdominal obesity was assessed using waist-to-hip ratios
(WHR = waist/hip). Waist circumference (cm) was
measured using a tension-regulated tape measure along
a horizontal line at the level of the anterior superior iliac
spine. Hip circumference was measured along a horizontal line at maximum posterior extension of the buttocks.
All anthropometric measurements were repeated three
times by a pair of trained interviewers. Averages of the
repeated measurements were used in all calculations and
analyses.
Blood pressure measurements

Systolic blood pressure (SBP) and diastolic blood
pressure (DBP) were measured using a manual

Blood sample analysis

The subjects fasted for at least 8 h prior to participating
in the study. Following resting blood pressure measurements, a trained phlebotomist drew intravenous blood
samples on site. Blood samples were collected in vacutainer tubes and immediately spun at 3500 rpm for
10 min. Samples were stored in the field at 4 °C until they
were transferred to a local lab for analysis within 5 h of
collection (Netlab, Quito, Ecuador). Blood samples were
analyzed in a laboratory using a method that is NGSP
certified and standardized to the DCCT assay for triglyceride (TG) levels, high density cholesterol (HDL), total
cholesterol (TC), hemoglobin A1c (HbA1c) and fasting blood glucose (FBG). Very low density lipoprotein
(VLDL) and low density lipoprotein (LDL) cholesterol
were calculated.
Blood glucose levels were measured with the enzymatic
method GOD-PAP [17]. The field research team experienced an equipment error (centrifuge) on one of the testing days in the field. As a result, the FBG readings from
53 participants from the Cariamanga sample were not
usable and were excluded from the analyses.
Data analysis

Multivariate analysis of variance (MANOVA) was separately applied to risk factors (HbA1c, TC, HDL, TG, LDL
and VDL) and demographic factors as a set of dependent
variables (DVs) with sex, location and their interaction
included as predictors. The MANOVA model was followed by a univariate multiple regression model for each
DV. If MANOVA F-tests were significant, the univariate
models were tested without any adjustment; otherwise,
the Holm’s method was applied. Extreme outliers were
defined as participants who had standardized residuals greater than 4.5 in any of the variables. All tests were
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Table 1 Frequency distributions by sex and location
Total
n
Total sample

Male
%

433

Female

n

%

n

%

138

31.9

295

68.1

Location
Cariamanga

214

49.4

67

31.3

147

68.7

Pomasqui

219

50.6

71

32.4

148

67.6

performed 2-tailed at the significance level of 5%. Data
were analyzed using IBM SPSS version 22 [18] and the R
statistical language version 3.2 [19].
TC, HDL, BMI, FBG and HbA1C were normally distributed for sex groups, and there was homogeneity of
variance as assessed by Levene’s Test for Equality of Variances. Therefore, an independent t-test was run on the
data as well as 95% confidence intervals (CI) for the mean
difference. The values for the TG, LDL and VLDL were
positively skewed. Therefore, a Mann–Whitney U test
was run on these data.

Results
A total of 433 adolescents participated in the study
(Table 1). The number of adolescents in Cariamanga
(49.4%) was similar to the number of adolescents in
Pomasqui (50.6%). There were more female (68.1%)
than male (31.9%) participants in both locations. Table 2
summarizes descriptive statistics of the overall sample
as well as by sex and location. The mean age of all adolescents was 15.1 ± 1.6 years with a mean BMI for age
of 20.7 ± 3.4 kg/m2, and WHR of 0.83 ± 0.1. Using the
IOTF classification system, 9.8% of the total sample was
overweight and 1.9% was obese. Table 3 compares results
of overweight status and obesity using WHO [13] and
IOTF [14] classification systems.
Of the 428 samples successfully drawn, a total of 375
adolescents had valid FBG measures. Of these, no adolescents had glucose >126 mg/dL. Six (1.6%) of the adolescents had FBG levels 100–126 mg/dL, indicative
of prediabetes. A total of 428 adolescents had a valid
HbA1c. None had an HbA1c ≥6.5% (48 mmol/mol), but
53 (12.4%) had an HbA1c 5.7–6.4% (39–46 mmol/mol),
indicative of prediabetes.
Ten (2.3%) adolescents (six girls and four boys) over
16 years old met the IDF criteria for metabolic syndrome
in children and adolescents, evenly distributed between the
two locations. None of the adolescents under 16 met the
IDF criteria. In addition to waist circumference, low HDL
was the one risk factor common to all ten adolescents who
met the IDF for metabolic syndrome. High triglycerides
were present in five of the ten adolescents with metabolic
syndrome. Elevated glucose was present in only one of the

ten. Four (two girls and two boys) of the ten with metabolic
syndrome also had prediabetes based on HbA1c.
Girls versus boys

As expected, there were some significant differences in
anthropometric data between boys and girls. Table 3 presents the percentages of overweight and obese by WHO
and IOTF classification for both males and females. Girls
had higher BMI compared to boys (p < 0.001). Boys had
higher SBP (p = 0.003) and DBP (p = 0.05) than girls.
Girls had higher TC (p < 0.001), LDL (p < 0.001), HDL
(p = 0.01), VLDL (p = 0.01) and TG (p = 0.009) than
boys. There were no significant sex differences in HbA1c
(p = 0.32). Of the adolescents 16 and older, 33% (39/119)
girls had a waist circumference ≥80 cm, and 12% (6/51)
boys had a waist circumference ≥90 cm.
Location differences

Using the IOTF weight classification system, 9.8% of the
total sample was overweight, and 1.9% was obese. Total
overweight and obesity rates combined were 14.5% in
Cariamanga and 8.9% in Pomasqui based on IOTF criteria. Adolescents from Pomasqui had similar rates of
obesity (2.8%) to adolescents from Cariamanga (0.9%).
While there were no significant differences in rate of
obesity by location, adolescents from the smaller urban
center of Cariamanga did have higher rates of overweight
(13.6%) than adolescents from the larger urban center of
Pomasqui (6.1%), using the IOTF criteria. Adolescents
from Cariamanga had higher WHRs (0.85 ± 0.04) than
(0.82 ± 0.06) adolescents from Pomasqui (p < 0.001).
There was a higher proportion of overweight adolescents
in Cariamanga than in Pomasqui (p = 0.018) but no significant difference in obese adolescents (p = 0.30).
Adolescents from Pomasqui had higher prevalence of
prediabetes (HbA1c 5.7–6.5%; 39–46 mmol/mol) (16.8%)
than adolescents from Cariamanga (1.9%) (p < 0.001)
and higher FBG (p < 0.001) than adolescents Cariamanga. Adolescents from Pomasqui also had higher TC
(p < 0.001), LDL (p < 0.001), VLDL (p = 0.02), and TG
(p = 0.03). In contrast, HDL was lower in adolescents
from Cariamanga (p < 0.001). Adolescents from Pomasqui had higher SBP (p = 0.03) and DBP (p < 0.001).

n

428

428

HDL (mg/dL)

TC (mg/dL)

149.6

50.6

81.9

5.4

76.3

69.0

103.3

20.7

36.1

14.7

9.5

0.3

14.4

8.5

10.8

3.4

0.05

8.3

8.9

9.9

7.9

1.6

SD

428 15 [12–20] (5–73)

VLDL (mg/dL)

212

212

161

212

214

214

214

214

214

214

214

214

214

214

n

145

145

114

145

147

147

147

147

147

147

147

147

147

147

n

79 [62–99] (24–183)

145 15 [11–19] (5–7)

145

145.8

47.9

79.2

5.3

77.8

70.3

103.4

21.2

0.85

87.3

74.2

49.2

152.4

14.8

Mean

Median [interquartile
range](range)

39.8

15.7

10.4

0.3

17.6

8.1

10.6

3.2

0.04

7.9

8.3

9.5

7.5

1.5

SD

145 75 [54–95] (25–367)

n

137.8

46.3

79.4

5.3

77.8

71.0

104.4

20.6

0.85

86.4

73.1

49.2

154.1

14.8

Mean

SD
1.5

Mean

SD

67

14.8

120.4

42.7

80.1

5.3

77.8

72.7

106.6

19.5

0.84

84.2

70.7

49.1

157.8

1.5

38.0

16.9

13.2

0.3

18.1

8.8

10.6

3.0

0.05

9.6

9.5

11.5

10.0

65 [47–83] (25–202)

Median [interquartile
range](range)

67

67

67

67

67

67

67

67

67

67

67

67

67

67 13 [9.5–17] (5–40)

67 62 [47.5–80] (25–137)

67

n

38.1

14.8

9.1

0.2

17.4

7.7

10.4

3.2

0.04

6.8

7.5

8.5

5.3

n

27.5

12.3

8.4

0.3

10.0

8.5

10.9

3.6

0.06

7.9

9.3

10.2

7.9

1.6

SD

147

147

145

147

145

147

145

145

145

145

145

148

14

148

n

Median [interquartile
range](range)

161.3

54.8

83.8

5.4

74.8

67.2

102.1

20.7

0.82

91.2

74.6

51.5

157.3

15.4

Mean

147 17 [14–21] (8–57)

147 89 [76–105.5] (44–161)

165.5

55.8

83.0

5.4

77.0

66.8

100.9

21.1

69

69

69

68

69

71

69

69

69

69

69

71

69

71

n

152.2

52.8

85.4

5.5

70.2

68.1

104.7

19.9

0.83

88.6

73.9

53.5

163.2

15.4

Mean

a

Data are represented as mean ± SD, except for TG, LDL, and VLDL who are represented as median [IQR] and (range)

24.9

12.3

7.7

0.3

9.0

9.2

12.7

3.3

0.05

8.3

8.9

11.6

8.7

1.7

SD

81 [71–95] (17–142)

76 [61–93] (41–302)

Median [interquartile range]
(range)

27.8

12.3

8.5

0.3

9.8

8.2

9.7

3.7

0.06

7.5

9.5

9.4

5.7

1.7

SD

Male

69 15 [12–19] (8–60)

69

69

n

0.81

92.5

74.9

50.5

154.6

15.4

Mean

Female

147 85 [69–103] (41–285)

n

216

216

214

215

214

218

214

214

214

214

214

219

214

219

n

All

Male

All

Female

Pomasqui sample

Cariamanga sample

WHR wait-to-hip ratio; BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; HbA1c glycated hemoglobin; TC total cholesterol; TG triglyceride; HDL high density lipoprotein; LDL low density
lipoprotein; VLDL very low density lipoprotein; FBG fasting blood glucose

428 76 [59–98] (25–367)

428 81 [64–98] (17–183)

TG (mg/dL)

LDL (mg/dL)

Median [interquartile
range](range)a

427

375

HbA1c (mg/dL)

FBG (mg/dL)

428

428

SBP (mmHg)

428

428

DBP (mmHg)

0.83

428

WHR

BMI (kg/m2)

HR (bpm)

88.8

428

Hip (cm)

50.4

73.8

433

428

Weight (kg)

Waist (cm)

155.7

15.1

433

428

Age (years)

Height (cm)

Mean

n

Overall

Table 2 Characteristics of sample overall and by location and sex
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Table 3 Percent of sample with each weight class and HbA1c range overall and by location
Overall
n

%

Cariamangaa

Pomasquia

n

n

%

Maleb
%

n

Femalea
%

n

%

WHO weight c lassificationc
Underweight

31

7.3

14

6.5

17

8.0

17

12.5

14

4.8

328

76.8

162

75.7

166

77.9

105

77.2

223

76.6

Overweight

41

9.6

22

10.3

19

8.9

9

6.6

32

11.0

Obese

27

6.3

16

7.5

11

5.2

5

3.7

22

7.6

Thinness grade 3

15

3.5

8

3.7

7

3.3

8

5.9

7

2.4

Thinness grade 2

37

8.7

17

7.9

20

9.4

19

14.0

18

6.2

Thinness grade 1

69

16.2

33

15.4

36

16.9

27

19.9

42

14.4

Healthy weight

256

60.0

125

58.4

131

61.5

73

53.7

183

62.9

42

9.8

29

13.6

13

6.1

6

4.4

36

12.4

8

1.9

2

0.9

6

2.8

3

2.2

5

1.7

374

87.6

200

174

115

53

12.4

12

41

20

0

0

0

Healthy weight

IOTF weight classification

Overweight
Obese
HbA1c status
HbA1c <5.7
HbA1c 5.7–6.4
a
b
c

HbA1c ≥6.5

0

0

0

0

259
33
0

0

0

Applying Chi square test, there is no significant difference
Applying Chi square test, there is significant difference P = 0.009 WHO Class and P = 0.002 IOTF Class

Classification using percentiles

Table 4 Regression analyses of the cardiometabolic risk factors, anthropometrics and hemodynamics
(Intercept)
HbA1c (units)

5.28 ± 0.02***

FBG (mg/dL)

79.17 ± 0.87***

TG (mg/dL)
TC (mg/dL)
VLDL (mg/dL)
LDL (mg/dL)
Hip (cm)

0.85 ± 0.0***

SBP (mmHg)
DBP (mmHg)

21.16 ± 0.28***

103.44 ± 0.88***
70.26 ± 0.68***

Data are expressed as β ± standard error

−0.01 ± 0.05

−25.4 ± 4.86***

19.72 ± 3.85***

12.04 ± 6.84

1.85 ± 0.91*

1.11 ± 1.62

−5.27 ± 2.06*

81.58 ± 2.09***

0.15 ± 0.03***

3.85 ± 1.16**

47.94 ± 1.16***

74.22 ± 0.72***

BMI (kg/m2)

0.04 ± 0.04

Sex x location

0.90 ± 1.61

−13.11 ± 5.74*

16.46 ± 0.65***

Waist (cm)

Location (urban)

82.17 ± 3.23***

145.8 ± 2.73***

HDL (mg/dL)

Sex (male)

−2.61 ± 1.15*

−16.52 ± 3.72***
−3.49 ± 1.29**

−0.01 ± 0.01

−1.68 ± 0.49***
3.11 ± 1.57*

2.42 ± 1.22*

9.5 ± 4.55*

7.82 ± 1.63***

9.86 ± 2.95***

0.68 ± 1.03

1.49 ± 2.10

5.66 ± 8.07

2.26 ± 2.9

7.64 ± 5.23

2.47 ± 1.82

−0.04 ± 0.01***

0.03 ± 0.01***

−2.59 ± 1.24*

0.76 ± 2.2

−0.1 ± 0.39

−3.46 ± 0.97***

0.51 ± 0.69

−1.15 ± 1.71

WHR wait-to-hip ratio; BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; HbA1c glycated hemoglobin; TC total cholesterol; TG
triglyceride; HDL high density lipoprotein; LDL low density lipoprotein; VLDL very low density lipoprotein; FBG fasting blood glucose
* p < 0.05, ** p < 0.01, *** p < 0.001

Sex by location interaction

Both sex and location were significant predictors of
the six cardiometabolic risk factors (HbA1c, TC, HDL,
TG, LDL and VLDL) as a set [sex: Wilk’s λ = 0.93, F(6,
418) = 5.2, p < 0.001; location: Wilk’s λ = 0.87, F(6,
418) = 10.1, p < 0.001], while their interaction was not
(Wilk’s λ = 0.99, F(6, 418) = 0.8, p > 0.05). Specifically,
sex was associated with all risk factors (ps < 0.05) except

for HbA1c (p > 0.05) after controlling for location. Location was significantly associated with all risk factors
(ps < 0.05) after controlling for sex. The location by sex
interaction was not significant for any of the risk factors
(ps > 0.05).
Table 4 summarizes the results of the regression models, showing how sex and location influenced the prevalence of the cardiometabolic risk factor. All risk factors,
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except for HbA1c, were significantly associated with both
sex and location. Specifically, boys had lower levels of TC,
HDL, LDL, TG and VLDL than girls regardless of location (ps < 0.05). Adolescents from Pomasqui had higher
values of all risk factors, regardless of sex (ps < 0.05). Sex
and location did not interact to influence any of the cardiometabolic risk factors (ps > 0.5).
The multivariate F-test revealed that waist circumference, WHR, BMI, as well as SBP and DBP were significantly affected by both sex and location as well as
their interaction [sex: Wilk’s λ = 0.95, F(5, 420) = 4.8,
p < 0.001; location: Wilk’s λ = 0.72, F(5, 420) = 32.6,
p < 0.001; interaction: Wilk’s λ = 0.97, F(5, 420) = 2.9,
p = 0.01). Specifically, sex was significantly associated
with waist, BMI, SBP, and DBP (ps < 0.05) after controlling for location, while location alone was associated with
WHR, SBP, and DBP (ps < 0.05). Sex and location interacted to affect WHR only (p < 0.001). In Cariamanga,
boys and girls did not differ in WHR (p > 0.05), while in
the Pomasqui, boys had higher WHR (p < 0.001). Conversely, girls from Cariamanga had higher WHR than
girls from Pomasqui (p < 0.001) while boys did not differ
between locations (p > 0.05). Regarding the other variables, waist, BMI, SBP, and DBP were all affected by sex
(p < 0.05). Specifically, boys had lower waist and BMI,
but higher SBP and DBP measures than girls, regardless of location. Adolescents from Pomasqui had lower
SBP and DBP than their counterparts from Cariamanga
(ps < 0.05) regardless of sex.

Discussion
There were several notable findings from this study. First,
the prevalence of overweight and obesity in the overall sample were lower than anticipated based on previous research in this region [11, 12]. Second, there were
relatively low rates of biochemical metabolic abnormalities (dyslipidemia and hyperglycemia) and only 2.3% met
the IDF criteria for metabolic syndrome. Third, despite
these factors, almost 10% of the adolescents (n = 43) in
the sample met the diagnostic criteria for prediabetes.
Finally, the rate of prediabetes was eight times higher in
adolescents from the large urban center of Pomasqui as
compared to the smaller urban center of Cariamanga.
Based on census data and recent studies mentioned
previously, higher rates of metabolic abnormalities (dyslipidemia and hyperglycemia) were expected in the overall sample. Only 2.3% of adolescents (n = 10) met the
IDF criteria for metabolic syndrome. The higher rates of
cardiometabolic risk factors in the larger urban center
of Pomasqui may reflect the availability of a more westernized diet, as has been suggested in previous research
in LMICs [5]. However, it was surprising that the rates
of overweight were higher in the smaller urban areas of
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Cariamanga (13.6%) compared to the larger urban center
of Pomasqui (6.1%). The authors believe that the findings
demonstrate that the problem of excess weight is spreading to smaller communities in Ecuador and that these
more rural regions, farther from larger urban centers, are
also experiencing the early stages of nutrition transition.
Nearly 10% of adolescents in the sample had prediabetes based on an elevated HbA1c and rates were 8× higher
in the larger urban center of Pomasqui (16.8 vs 1.8%).
Both the differing rates of prediabetes and the higher
rates of overweight may indeed confirm that Ecuadorian
adolescents are in the midst of a nutrition transition [12].
These results may indicate that the effects of a western
lifestyle and diet are permeating more of the country,
even into the smaller and more remote urban areas in
southern Ecuador [12]. Of note, the American Diabetes
Association recommends screening any person above
the age of 10 who is obese and has at least 2 additional
risk factors for T2DM. This screening can be completed
using an A1c [20]. If screenings in this study were limited
to this standard, a much smaller number of adolescents
would have been screened and many cases of prediabetes
would have been missed.
Previous research in the United States showed that the
HBA1c may be less sensitive than an oral glucose tolerance test (OGTT) to diagnose prediabetes and diabetes
[21]. However, OGTT are often not practical in rural
and underserved areas. The use of an OGTT has almost
been completely replaced by the A1c in adults. Because
of these challenges some authors have suggested that the
A1c is a necessary tool for the screening of dysglycemia
in adolescents [22]. A recent study actually showed that
current A1c cutoffs may underestimate diabetes rates in
adolescents [23].
The results of this study have important clinical implications for screening adolescents. Use of HbA1c identified more adolescents with prediabetes than FBG and
other metabolic markers. This has also been reported in
adults [24]. The HbA1c measure is an attractive screening tool for prediabetes in developing countries for several reasons: (1) it does not require the person to fast, (2)
it is available as a venous or capillary sample, and (3) it is
enzymatically easier to process than glucose [25]. Clearly,
if a more traditional biochemical risk factors were used
in this present study, fewer adolescents would have been
identified as at risk. Use of HbA1c could be used as a
screening tool to provide identification earlier on the
insulin resistance spectrum. The importance of early
identification in adolescence cannot be understated, as it
is now known that type 2 diabetes in childhood and adolescence is less responsive to treatment and that adolescents experience beta cell failure faster than others with
type 2 diabetes [26].
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This study has a number of limitations. While this is
a representative sample of adolescents in Quito and the
southern Sierra region of Ecuador, it does not represent
the diversity of adolescents in the country. Geographic
differences such as elevation could be confounding variables affecting some of our results. The study team did
not do Tanner staging on the participants which limits the confidence that we only included mature adolescents. Further, we did not assess participants for anemia
and cannot rule out that some of the participants had a
hemoglobinopathy. However, this would have resulted
in an under-estimation of diabetes rates. In this study
socioeconomic data were not collected, and as suggested by previous research [12, 27, 28], socioeconomic
factors could also be influencing our results. Finally, this
study measures a single point in time, and cannot predict the trajectory of these adolescents based on this
measurement alone. In light of the higher rates of overweight in the adolescents from the smaller urban center,
longitudinal follow up would be illustrative. The use of
HbA1c is also somewhat controversial. The OGTT is the
gold standard but in the U.S it has almost entirely been
replaced by the HbA1c due to the ease of testing.
Difficulties experienced in this study include not having longitudinal access to the study subjects and variability in the local resources. Due to inconsistent electricity,
we lost a substantial number of glucose readings because
centrifugation of the sample was inadequate and glycolysis occurred in the sample vials. Despite the limitations,
this study exposes some important differences that need
further investigation in order to identify those adolescents at greatest risk of chronic diseases. Additional studies to determine specific lifestyle factors that influence
these risk factors are currently being conducted with
adolescents in Ecuador. Future studies should continue
this work to determine what physiologic or environmental features best predict progression to or prevention of
diabetes. In the meantime strong consideration should be
placed on using the HbA1c for screening for diabetes and
prediabetes in LA adolescents.

Conclusions
In conclusion, this study found lower than anticipated
rates of overweight and obesity as well as relatively low
rates of biochemical metabolic abnormalities and metabolic syndrome. Notably, 10% of the adolescents in
the sample met the diagnostic criteria for prediabetes,
despite low levels of dyslipidemia and hyperglycemia.
Although rates of obesity in Ecuadorian adolescents are
low there is significant evidence to suggest that prediabetes is permeating the smaller urban centers. Perhaps
of most concern, and worthy of future study, is the clear
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and substantive disparity in rates of prediabetes in adolescents from the large urban center as compared to the
smaller urban center. Use of HbA1c identified more adolescents with prediabetes than FBG. The HbA1c measure
is an attractive screening tool for prediabetes in developing countries. Traditional screening tools may underestimate this risk.
This study builds upon important research describing the epidemiology of children and adolescents in
developing countries in LA. Developing countries with
public health systems that can recognize and respond
to these health challenges in the adolescent population
may be more able to slow the rise of many preventable
chronic diseases such as diabetes. The non-communicable chronic diseases such as diabetes, hypertension, and
non-alcoholic fatty liver disease will become an increasing burden for countries in transition if no action is taken
to reduce the precursors of these diseases in children and
adolescents.
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